From Empirico Raises $17M, Inks 3-Year Antisense Collaboration with Ionis:

Omri Gottesman

Omri Gottesman—

Headshot of Omri Gottesman courtesy of Empirico

Underwriters and Partners

Xconomy Insight

Sponsored · Video
The Importance of Early Planning for Biotechs & Engaging with a CRO for Molecule Development
A Fireside Chat with Medpace's Regulatory Affairs Director David Horton
Medpace

From Our Partners · Special Report
Robert Langer reveals secrets to early-stage biotech success
Advice for funding and future transformational opportunities

Sponsored · Whitepaper
What’s Next in Neuroscience Therapies
New approaches & tech are on the horizon that could change how researchers and clinicians approach brain and neurological disorders

Xconomy on Demand

We offer a number of ways to subscribe for free!